CD8A and neoplasm: These findings are supported by Horikawa et al. who demonstrated that MDSC suppress the CD8 T cells in the tumor microenvironment (34), suggesting that MDSC-induced immunosuppression might be one of the drivers of adaptive immunetolerance in ovarian cancer.